Literature DB >> 17545473

Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats.

Margaret P Chandler1, Eric E Morgan, Tracy A McElfresh, Theodore A Kung, Julie H Rennison, Brian D Hoit, Martin E Young.   

Abstract

Clinical studies have shown a greater incidence of myocardial infarction in diabetic patients, and following an infarction, diabetes is associated with an increased risk for the development of left ventricular (LV) dysfunction and heart failure. The goal of this study was to determine if the progression of heart failure following myocardial infarction in type 2 diabetic (T2D) rats is accelerated compared with nondiabetic rats. Male nondiabetic Wistar-Kyoto (WKY) and T2D Goto-Kakizaki (GK) rats underwent coronary artery ligation or sham surgery to induce heart failure. Postligation (8 and 20 wk), two-dimensional echocardiography and LV pressure measurements were made. Heart failure progression, as assessed by enhanced LV remodeling and contractile dysfunction, was accelerated 8 wk postligation in the T2D animals. LV remodeling was evident from increased end-diastolic and end-systolic diameters and areas in the GK compared with the WKY infarcted group. Furthermore, enhanced LV contractile dysfunction was evident from a greater deterioration in fractional shortening and enhanced myocardial performance index (an index of global LV dysfunction) in the GK infarcted group. This accelerated progression was accompanied by greater increases in atrial natriuretic factor and skeletal alpha-actin (gene markers of heart failure and hypertrophy) mRNA levels in GK infarcted hearts. Despite similar decreases in metabolic gene expression (i.e., peroxisome proliferator-activated receptor-alpha-regulated genes associated with fatty acid oxidation) between infarcted WKY and GK rat hearts, myocardial triglyceride levels were elevated in the GK hearts only. These results, demonstrating enhanced remodeling and LV dysfunction 8 wk postligation provide evidence of an accelerated progression of heart failure in T2D rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545473     DOI: 10.1152/ajpheart.01338.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

1.  Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.

Authors:  Martine Desrois; Kieran Clarke; Carole Lan; Christiane Dalmasso; Mark Cole; Bernard Portha; Patrick J Cozzone; Monique Bernard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

2.  Voltage dependence of the Ca2+ transient in endocardial and epicardial myocytes from the left ventricle of Goto-Kakizaki type 2 diabetic rats.

Authors:  Lina Al Kury; Vadym Sydorenko; Manal M A Smail; Muhammad Anwar Qureshi; Anatoliy Shmygol; Murat Oz; Jaipaul Singh; Frank Christopher Howarth
Journal:  Mol Cell Biochem       Date:  2018-01-09       Impact factor: 3.396

3.  Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population.

Authors:  Vita Ignatovica; Gustavs Latkovskis; Raitis Peculis; Kaspars Megnis; Helgi B Schioth; Iveta Vaivade; Davids Fridmanis; Valdis Pirags; Andrejs Erglis; Janis Klovins
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

4.  C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform.

Authors:  Yuexing Yuan; Wayne Bond Lau; Hui Su; Yang Sun; Wei Yi; Yunhui Du; Theodore Christopher; Bernard Lopez; Yajing Wang; Xin-Liang Ma
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-03-17       Impact factor: 4.310

Review 5.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

6.  Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction.

Authors:  Christos Kalofoutis; Iordanis Mourouzis; Georgios Galanopoulos; Antonios Dimopoulos; Philippos Perimenis; Danai Spanou; Dennis V Cokkinos; Jaipaul Singh; Constantinos Pantos
Journal:  Mol Cell Biochem       Date:  2010-08-22       Impact factor: 3.396

Review 7.  Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy.

Authors:  Mark T Waddingham; Amanda J Edgley; Hirotsugu Tsuchimochi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  World J Diabetes       Date:  2015-07-10

Review 8.  Stem cells in the diabetic infarcted heart.

Authors:  Carley E Glass; Pawan K Singal; Dinender K Singla
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

9.  The chronic effects of neonatal alloxan-induced diabetes mellitus on ventricular myocyte shortening and cytosolic Ca2+.

Authors:  Frank Christopher Howarth; Zahra Hassan; Muhammad Anwar Qureshi
Journal:  Mol Cell Biochem       Date:  2010-10-13       Impact factor: 3.396

10.  Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat.

Authors:  Erik Vahtola; Marjut Louhelainen; Hanna Forstén; Saara Merasto; Johanna Raivio; Petri Kaheinen; Ville Kytö; Ilkka Tikkanen; Jouko Levijoki; Eero Mervaala
Journal:  Cardiovasc Diabetol       Date:  2010-01-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.